Precision Business Insights has published a report on the global cancer biomarker market, estimating its value at USD 21.15 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 11.5% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/global-cancer-biomarker-market
The Cancer Biomarker Market is a global industry dedicated to the creation, manufacture, and use of biomarkers—biological molecules that signal the presence or advancement of cancer—for use in diagnostics, prognostics, medication development, and individualized treatment techniques.
Drivers:
1) Advancements in Omics Technologies: Innovations in genomics, proteomics, and metabolomics enable more precise biomarker discovery and integration with clinical data.
2) Growth in Personalized Medicine: Biomarkers are central to oncology precision medicine, helping tailor therapies to individual molecular profiles.
The global cancer biomarker market segmentation:
1) By Biomarker Type: Protein Biomarker, Genetic Biomarker, Others
2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Non-Hodgkin's Lymphoma, Bladder Cancer, Kidney Cancer, Liver Cancer, Others
3) By Profiling Technology: OMICS Technology, Imaging Technology, Immunoassays, Cytogenetics, Bioinformatics, Others
4) By Application: Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, Others
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=38361
Regional Overview:
The report also examines the current concerns and their Future Effects on the cancer biomarker market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the cancer biomarker market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like Thermo Fisher Scientific, Inc., Illumina, Inc., Hoffmann La Roche Ltd., Hologic, Inc., Creative Diagnostics, Quest Diagnostics, Bio-Rad Laboratories Inc., Abbott Laboratories, Exact Sciences, Meso Scale Diagnostics LLC, Seegene Technologies Inc., Siemens Healthineers
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
Comments
0 comment